Reference control for high-sensitivity C-reactive protein testing

• US 6,548,646 B1
• Filed: 08/23/2001
• Issued: 04/15/2003
• Est. Priority Date: 08/23/2001
• Status: Expired due to Term

• Current Assignee: Bio-Rad Laboratories Incorporated
• Original Assignee: Bio-Rad Laboratories Incorporated
• Inventors: Ebrahim, Alireza, Parikh, Jayshree, Vanderslice, Warren Eric
• Primary Examiner(s): Weber, Jon P.
• Application Number:
  US09/938,409
• Time in Patent Office: 600 Days
• Field of Search: 530/380, 530/415, 530/417
• US Class Current: 530/415
• CPC Class Codes: G01N 2333/4737 C-reactive protein
• CPC Class Codes: G01N 33/6893 related to diseases not provided for elsewhere

Abstract

Low-concentration reference controls for C-reactive protein assays are prepared from higher-level starting materials by simple filtration using silica-type filter media formerly used for removing lipids. This process avoids the need for antibodies to capture the protein and resuspend it. Surprisingly, the removal of CRP by the silica-type filter media is selective toward CRP, having little or negligible effect on other proteins in the starting matrix, and accordingly little or negligible change in the total protein content.

Claims

1. A method for preparing a C-reactive protein reference control defined as a fluid having a target C-reactive protein concentration of less than 0.1 mg/L from a sample of human bodily fluid having a total protein concentration of at least about 4.0 g/dL, said method comprising:

(a) adjusting the pH of said sample to a pH within the range of from about 6.5 to about 7.5, when said sample is not within said range, to achieve a substantially neutral sample; and

(b) passing said substantially neutral sample through a filter medium selected from the group consisting of precipitated silica, fumed silica, perlite, and precipitated silica, fumed silica, and perlite supported on cellulose, to extract C-reactive protein therefrom by filtration selectively relative to other proteins in said sample and thereby achieve said target C-reactive protein concentration.

2. A method in accordance with claim 1 further comprising adding an antimicrobial agent to the product of step (b).

3. A method in accordance with claim 1 in which said human bodily fluid is a member selected from the group consisting of blood, serum, and plasma.

4. A method in accordance with claim 1 in which said human bodily fluid is a member selected from the group consisting of serum and plasma.

5. A method in accordance with claim 1 in which silica-containing filter medium is a member selected from the group consisting of fumed silica and perlite.

6. A method in accordance with claim 1 in which silica-containing filter medium is a member selected from the group consisting of fumed silica and perlite, supported on cellulose.

7. A method in accordance with claim 1 in which said target C-reactive protein concentration is less than 0.05 mg/L.

8. A method in accordance with claim 1 in which said target C-reactive protein concentration is between 0.01 mg/L and 0.05 mg/L.